Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. The journal seeks to publish research papers that demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results. Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. As with other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was 25.430, making it the highest-cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.
Some can jump research paper paywall thanks to Nature group
Research band at Karolinska tuck Dylan gems into papers
Eye implant could lead to better glaucoma treatment
For the 2.2 million Americans battling glaucoma, the main course of action for staving off blindness involves weekly visits to eye specialists, who monitor—and control—increasing pressure within the eye.
Galectins direct immunity against bacteria that employ camouflage
Our bodies produce a family of proteins that recognize and kill bacteria whose carbohydrate coatings resemble those of our own cells too closely, scientists have discovered.
New technique for visualizing blood flow involves carbon nanotubes and lasers
(Phys.org)—Stanford scientists have developed a fluorescence imaging technique that allows them to view the pulsing blood vessels of living animals with unprecedented clarity. Compared with conventional ...
Nanoparticle Tracking Analysis technology facilitates cancer metastasis research
NanoSight, leading manufacturers of unique nanoparticle characterization technology, reports on the breakthrough cancer metastasis research of Dr. Hector Peinado Selgas and Dr. David Lyden's research team ...
Novel use of nanoparticles target non-invasive treatment for deep cancer
National University of Singapore (NUS) researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of ...